4-aminoquinoline has been researched along with Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chauhan, B; Khede, MK; Nandi, S; Tarannum, H | 1 |
Lee, H; Pundir, S; Solomon, VR | 1 |
Al-Said, MS; Arafa, RK; Ghorab, MM | 1 |
Arimondo, PB; Ausseil, F; Bouhlel, MA; Cantagrel, F; David-Cordonnier, MH; Dufau, I; Faux, C; Fleury, L; Gros, C; Labella, D; Lacroix, L; Mai, A; Mourey, L; Nahoum, V; Rilova, E; Valente, S | 1 |
4 other study(ies) available for 4-aminoquinoline and Neoplasms
Article | Year |
---|---|
Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and Cancer.
Topics: Aminoquinolines; Humans; Malaria; Neoplasms; Polypharmacology; Tuberculosis | 2023 |
Examination of novel 4-aminoquinoline derivatives designed and synthesized by a hybrid pharmacophore approach to enhance their anticancer activities.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Neoplasms | 2019 |
Design, synthesis and potential anti-proliferative activity of some novel 4-aminoquinoline derivatives.
Topics: Aminoquinolines; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Design; Female; Humans; Inhibitory Concentration 50; MCF-7 Cells; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2014 |
New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.
Topics: Aminoquinolines; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Epigenomics; Humans; Neoplasms; Pyrimidines | 2015 |